Egypt - English - EDA (Egyptian Drug Authority)

glaxo smithkline-egypt - tablet - 3 mg

Malta - English - Medicines Authority

mercury pharmaceuticals limited - warfarin sodium 0.5 mg - tablet

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - warfarin sodium - oral tablet - 3mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - warfarin sodium - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - warfarin sodium - oral tablet - 500microgram

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

therabel pharma sa-nv - warfarin sodium 5 mg - eq. warfarin 4,67 mg - tablet - 5 mg - warfarin sodium 5 mg - warfarin

Australia - English - Department of Health (Therapeutic Goods Administration)

evergrowth pty ltd - propolis resin, quantity: 200 mg/ml (equivalent: lead, qty 2 microgram/ml; equivalent: propolis, qty 300 mg/ml) - liquid, multipurpose - excipient ingredients: propylene glycol - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; decrease/reduce/relieve symptoms of mild mouth ulcers ; traditionally used in chinese medicine to decrease/reduce/relieve mild throat inflammation ; traditionally used in western herbal medicine to decrease/reduce/relieve mild throat inflammation ; decrease/reduce/relieve mild throat inflammation ; traditionally used in chinese medicine to decrease/reduce/relieve symptoms of mild throat infection ; traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of mild throat infection ; decrease/reduce/relieve throat mucous membrane irritation/inflammation ; helps decrease/reduce/relieve symptoms of minor skin wounds (cuts, scratches and abrasions) ; traditionally used in western herbal medicine to maintain/support wound healing ; traditionally used in chinese medicine to maintain/support wound healing

Australia - English - Department of Health (Therapeutic Goods Administration)

h c l manufacturers pty ltd - propolis dry extract -

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - warfarin sodium, quantity: 2 mg - tablet, uncoated - excipient ingredients: lactose; magnesium stearate; maize starch; stearic acid; amaranth aluminium lake; indigo carmine aluminium lake - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation. coumadin is not indicated in patients with lone atrial fibrillation who are less than 60 years of age with no risk factors (eg previous thromboembolism (tia, ischaemic stroke), diabetes mellitus, hypertension) and an otherwise normal heart. coumadin is indicated for use as an adjunct in the treatment of coronary occlusion.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - warfarin sodium, quantity: 5 mg - tablet, uncoated - excipient ingredients: maize starch; stearic acid; lactose; magnesium stearate; quinoline yellow aluminium lake; brilliant blue fcf aluminium lake - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation. coumadin is not indicated in patients with lone atrial fibrillation who are less than 60 years of age with no risk factors (eg previous thromboembolism (tia, ischaemic stroke), diabetes mellitus, hypertension) and an otherwise normal heart. coumadin is indicated for use as an adjunct in the treatment of coronary occlusion.